Subscribe
shutterstock_1169047330_markvanscyoc-1
markvanscyoc / shutterstock.com
7 May 2020Americas

USPTO temporarily allows online plant patent filings

The US Patent and Trademark Office (USPTO) will allow plant patent applications to be filed online due to the COVID-19 pandemic, it has announced.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Patent filing strategies for pharma startups
16 March 2021   Patents are a key asset for pharmaceutical startups, but where are they choosing to file? Jian Siang Poh and Angus Fairbairn of Marks & Clerk report.
Americas
US customs raids find thousands of fake COVID-19 test kits
5 May 2020   US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.
Africa
Plant breeders facing ‘critical situation’ ask nations for support
9 April 2020   The International Community of Breeders of Asexually Reproduced Ornamental and Fruit Varieties has implored countries to implement support measures for breeders amid the pandemic.


Editor's picks

‘We created law’: G1/24 and the creation of the ‘diamond standard’
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

Editor's picks

Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Big Pharma
Patent filing strategies for pharma startups
16 March 2021   Patents are a key asset for pharmaceutical startups, but where are they choosing to file? Jian Siang Poh and Angus Fairbairn of Marks & Clerk report.
Americas
US customs raids find thousands of fake COVID-19 test kits
5 May 2020   US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.
Africa
Plant breeders facing ‘critical situation’ ask nations for support
9 April 2020   The International Community of Breeders of Asexually Reproduced Ornamental and Fruit Varieties has implored countries to implement support measures for breeders amid the pandemic.

More on this story

Big Pharma
Patent filing strategies for pharma startups
16 March 2021   Patents are a key asset for pharmaceutical startups, but where are they choosing to file? Jian Siang Poh and Angus Fairbairn of Marks & Clerk report.
Americas
US customs raids find thousands of fake COVID-19 test kits
5 May 2020   US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.
Africa
Plant breeders facing ‘critical situation’ ask nations for support
9 April 2020   The International Community of Breeders of Asexually Reproduced Ornamental and Fruit Varieties has implored countries to implement support measures for breeders amid the pandemic.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?